Fragile X Syndrome Treatment Market to Reach US$3.60 Billion by 2035 as Disease-Modifying Research Moves Beyond Symptom Management

The global Fragile X syndrome treatment market was valued at US$2.08 billion in 2025 and is projected to reach US$3.60 billion by 2035, expanding at a CAGR of 8.2% during 2026-2035. The market is entering a more selective phase in